Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Open access
3,671
Views
13
CrossRef citations to date
0
Altmetric
Coronaviruses
A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
Joy-Yan Lama Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of ChinaView further author information
, Yau-Yee Nga Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of ChinaView further author information
, Chun-Kit Yuena Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China;b Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, People’s Republic of Chinahttps://orcid.org/0000-0003-2646-2054View further author information
, Wan-Man Wonga Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China;c State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, People’s Republic of ChinaView further author information
, Kwok-Yung Yuena Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China;c State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, People’s Republic of China;b Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-2083-1552View further author information
& https://orcid.org/0000-0002-2083-1552View further author information
Kin-Hang Koka Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China;c State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, People’s Republic of China;b Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-3426-332XView further author information
https://orcid.org/0000-0003-3426-332XView further author information
Pages 964-967
|
Received 31 Jan 2022, Accepted 08 Mar 2022, Published online: 30 Mar 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.